Prunella stica inhibits the proliferation but not the prostaglandin production of Ishikawa cells

Life Sciences

Volumn 79, Issue 5, 2006, Pages 436-441

  Huang, Jaou Chen ^a   Ruan, Cheng Huai ^a   Tang, Kathy ^b   Ruan, Ke He ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TR Acupuncture and Herb Clinic   (United States)

Author keywords

Cyclooxygenase; Endometrial cancer; Endometriosis; Herbs; Traditional medicine

Indexed keywords

INTERLEUKIN 1BETA; PLANT EXTRACT; PROSTAGLANDIN; PRUNELLA STICA EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CHINESE MEDICINE; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PRUNELLA; PRUNELLA STICA;

CELL PROLIFERATION; CELLS, CULTURED; CYCLOOXYGENASE 2; DRUGS, CHINESE HERBAL; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; HUMANS; INTERLEUKIN-1; PLANT COMPONENTS; PROSTAGLANDINS; PRUNELLA;

EID: 33744975244     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.01.018     Document Type: Article

References (24)

1. Bensky D., Ganble A., and Kaptchuk T. Chinese Herbal Medicine, Compiled and Translated (1986), Eastland Press, Seattle, WA 81
2. Bruner K.L., Matrisian L.M., Rodgers W.H., Gorstein F., and Osteen K.G. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. The Journal of Clinical Investigation 99 (1997) 2851-2857
3. Bulun S.E., Gurates B., Fang Z., Tamura M., Sebastian S., Zhou J., Amin S., and Yang S. Mechanisms of excessive estrogen formation in endometriosis. Journal of Reproductive Immunology 55 (2002) 21-33
4. Gravanis A., and Gurpide E. Effects of estradiol on deoxyribonucleic acid polymerase alpha activity in the Ishikawa human endometrial adenocarcinoma cell line. The Journal of Clinical Endocrinology and Metabolism 63 (1986) 356-359
5. Hill J.A. Immunology and endometriosis. Fertility and Sterility 58 (1992) 262-264
6. Hurst B.S., and Rock J.A. Endometriosis: pathophysiology, diagnosis, and treatment. Obstetrical and Gynecological Survey 44 (1989) 297-304
7. Kauppila A., Puolakka J., and Ylikorkala O. Prostaglandin biosynthesis inhibitors and endometriosis. Prostaglandins 18 (1979) 655-661
8. Khorram O., Taylor R.N., Ryan I.P., Schall T.J., and Landers D.V. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. American Journal of Obstetrics and Gynecology 169 (1993) 1545-1549
9. Koike H., Egawa H., Ohtsuka T., Yamaguchi M., Ikenoue T., and Mori N. Correlation between dysmenorrheic severity and prostaglandin production in women with endometriosis. Prostaglandins, Leukotrienes, and Essential Fatty Acids 46 (1992) 133-137
10. Kotani N., Oyama T., Sakai I., Hashimoto H., Muraoka M., Ogawa Y., and Matsuki A. Analgesic effect of a herbal medicine for treatment of primary dysmenorrhea-a double-blind study. The American Journal of Chinese Medicine 25 (1997) 205-212
11. Lebovic D.I., Mueller M.D., and Taylor R.N. Immunobiology of endometriosis. Fertility and Sterility 75 (2001) 1-10
12. Lindsey K., Jager A.K., Raidoo D.M., and van Staden J. Screening of plants used by southern African traditional healers in the treatment of dysmenorrhoea for prostaglandin-synthesis inhibitors and uterine relaxing activity. Journal of Ethnopharmacology 64 (1999) 9-14
13. Lyseng-Williamson K.A., and Fenton C. Docetaxel: a review of its use in metastatic breast cancer. Drugs 65 (2005) 2513-2531
14. Mahutte N.G., and Arici A. Medical management of endometriosis-associated pain. Obstetrics and Gynecology Clinics of North America 30 (2003) 133-150
15. Noble L.S., Simpson E.R., Johns A., and Bulun S.E. Aromatase expression in endometriosis. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 174-179
16. Osteen K.G., Bruner K.L., and Sharpe-Timms K.L. Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Seminars in Reproductive Endocrinology 14 (1996) 247-255
17. Rew D.A., and Wilson G.D. Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations. European Journal of Surgical Oncology 26 (2000) 227-238
18. Sharpe-Timms K.L., Penney L.L., Zimmer R.L., Wright J.A., Zhang Y., and Surewicz K. Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with tissue inhibitor of metalloproteinases-1 (TIMP-1). The Journal of Clinical Endocrinology and Metabolism 80 (1995) 3784-3787
19. Shin T.Y., Kim Y.K., and Kim H.M. Inhibition of immediate-type allergic reactions by Prunella vulgaris in a murine model. Immunopharmacology and Immunotoxicology 23 (2001) 423-435
20. Simpson J.L., Bischoff F.Z., Kamat A., Buster J.E., and Carson S.A. Genetics of endometriosis. Obstetrics and Gynecology Clinics of North America 30 (2003) 21-40 (vii)
21. Speroff L., Glass R.H., and Kase N.G. Endometriosis. Clinical Gynecologic Endocrinology and Infertility (1999), Lippincott Williams & Wilkins, Baltimore 1057-1074
22. Tanaka T. A novel anti-dysmenorrhea therapy with cyclic administration of two Japanese herbal medicines. Clinical and Experimental Obstetrics and Gynecology 30 (2003) 95-98
23. Zeitoun K., Takayama K., Sasano H., Suzuki T., Moghrabi N., Andersson S., Johns A., Meng L., Putman M., Carr B., and Bulun S.E. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 4474-4480
24. Zeitoun K., Takayama K., Michael M.D., and Bulun S.E. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Molecular Endocrinology 13 (1999) 239-253